hers glp-1 cost Hims & swings to a loss in Q1 amid shift in strategy Questions about Hers & compound

We may have entered a new era of metabolic medicine

Data also shows how rapidly these flagship products have come to fuel the majority of revenue for both companies, highlighting the revenue concentration characteristic of financialized business models

While Primes clinical teams share a deep dive of whats next in the GLP-1 pipeline in the quarterly GLP-1 Pipeline Update, lets explore some of the top GLP-1 drug pipeline trends

Insurance Coverage Note: Gala GLP-1 operates on a cash-pay, direct-to-consumer model

The results were similar to the initial trial, with (MDS-UPDRS-3) vs placebo - (published in Lancet)

doi:10.1001/jamapsychiatry.2025.4308 Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR